Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2022 05:13 ET | Source: Research and Markets

GPRC5D-Targeted Therapy Research 2022: Industry Perspective for Suitability as a Tumor-Specific Target for Cancer Therapy Based on its Expression Profile, Preclinical, Clinical Safety and Efficacy

Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis"...
July 21, 2022 07:28 ET | Source: Research and Markets

Insights on the GPRC5D-Targeted Therapy Market - Profiles of Companies Active in the Development of Anti-GPRC5D Therapy Candidates

Dublin, July 21, 2022 (GLOBE NEWSWIRE) -- The "GPRC5D-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis"...
April 05, 2022 04:33 ET | Source: Research and Markets

Global $33+ Billion CAR-T Cell Therapy Markets, 2017-2021 & 2022-2027: Focus on Yescarta, Kymriah, Tecartus, Breyanzi, Abecma

Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market, By Product Type, By Tumor Type, By Indication, By Treatment Type, By Targeted Antigen, By End User, By Region,...
December 20, 2021 06:28 ET | Source: Research and Markets

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight Research Report 2021-2026

Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's...
November 16, 2021 07:29 ET | Source: KuicK Research

B Cell Maturation Antigen BCMA Targeted Drug Therapy Market Insight 2026

Delhi, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Delhi,India: Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026 Report Analysis and Data Highlights: ...
September 28, 2021 04:28 ET | Source: Research and Markets

Global $6.13 Billion CAR-T Cell Therapy Markets, 2017-2020 & 2021-2026: Focus on Yescarta, Kymriah, Tecartus, Breyanzi, Abecma, Others

Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Markets, Competition Forecast & Opportunities, 2021-2026" report has been added to ResearchAndMarkets.com's offering. ...
September 21, 2021 04:23 ET | Source: Research and Markets

Global CAR-T Cell Therapy Market Research Report 2021: Approvals of Kymriah and Yescarta in Multiple Regions to Further Push Market Growth

Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen; By Indication; By Regions: Segment Forecast, 2021 - 2028"...